Skip to main content

Sniffer Dogs Can Be Used to Detect Lung Cancer, Research Suggests

Sniffer dogs could be used for the early detection of lung cancer, according to new research published in the European Respiratory Journal.
Sniffer dog training. (Credit: Image courtesy of European Lung Foundation)

The study, carried out by researchers from Schillerhoehe Hospital in Germany, is the first to find that sniffer dogs can reliably detect lung cancer.

Lung cancer is the second most frequent form of cancer in men and women across Europe with over 340,000 deaths per year. It is also the most common cause of death from cancer worldwide.

The disease is not strongly associated with any symptoms and early detection is often by chance. Current methods of detection are unreliable and scientists have been working on using exhaled breath specimens from patients for future screening tests.

This method relies on identifying volatile organic compounds (VOCs) that are linked to the presence of cancer. Although many different technological applications have been developed, this method is still difficult to apply in a clinical setting as patients aren't allowed to smoke or eat before the test, sample analysis can take a long time and there is also a high risk of interference. Because of these reasons, no lung cancer-specific VOCs have yet been identified.

This new study aimed to assess whether sniffer dogs could be used to identify a VOC in the breath of patients. The researchers worked with 220 volunteers, including lung cancer patients, chronic obstructive pulmonary disease (COPD) patients and healthy volunteers. They used dogs that had been specifically trained.

The researchers carried out a number of tests to see if the dogs were able to reliably identify lung cancer compared with healthy volunteers, volunteers with COPD and whether the results were still found with the presence of tobacco.

The dogs successfully identified 71 samples with lung cancer out of a possible 100. They also correctly detected 372 samples that did not have lung cancer out of a possible 400.

The dogs could also detect lung cancer independently from COPD and tobacco smoke. These results confirm the presence of a stable marker for lung cancer that is independent of COPD and also detectable in the presence of tobacco smoke, food odours and drugs.

Author of the study, Thorsten Walles from Schillerhoehe Hospital, said: "In the breath of patients with lung cancer, there are likely to be different chemicals to normal breath samples and the dogs' keen sense of smell can detect this difference at an early stage of the disease. Our results confirm the presence of a stable marker for lung cancer. This is a big step forward in the diagnosis of lung cancer, but we still need to precisely identify the compounds observed in the exhaled breath of patients. It is unfortunate that dogs cannot communicate the biochemistry of the scent of cancer!"

Comments

Popular posts from this blog

Final lunar eclipse of 2010 set for early morning of December 21

Skygazers hoping to catch the last lunar eclipse of 2010 on Tuesday morning best be ready to stay up late (or wake up very early) to watch the full moon as it goes through a range of dramatic color changes. The December 21 lunar eclipse is expected to last about three-and-a-half hours from its start as a partial eclipse at 1:33 a.m. ET to its finish at 5:01 a.m. ET, according to NASA. The previous lunar eclipse occurred June 26 . During a lunar eclipse, the moon, the Earth, and the sun align so that the sun's rays are shielded from the moon. An eclipse of the moon can only take place if the moon is full, and only if the moon passes through some portion of Earth's shadow, which is composed of two cone-shaped parts, one nested inside the other. The start of the total eclipse is expected around 2:41 a.m, when the entire moon passes through the Earth's umbra, or inner shadow, which blocks all direct sunlight from reaching the moon. The moon will tak...

Hand, Foot and Mouth Disease (HFMD) and Onychomadesis

  Introduction Nails are underutilized as diagnostic tools, despite being involved in many dermatologic conditions. This paper explores new concepts in the treatment of median nail dystrophy (MND), onychomycosis, and the nail pathology of hand, foot, and mouth disease (HFMD). A Pubmed database literature search was conducted for MND treatment, onychomycosis treatment, and HFMD nail pathology. Only papers published after January 2008 were reviewed. The results showed that 0.1% tacrolimus ointment can be an effective treatment for MND. Early studies on laser therapy indicate that it is a safe and efficacious treatment option for onychomycosis, compared to conventional oral antifungal agents. Vicks VapoRub (The Proctor & Gamble Company, Cincinnati, OH) is effective against onychomycosis and is a reasonable option in patients who choose to forgo conventional treatments. Lastly, there is evidence to support a correlation between HFMD and onychomadesis. ...

Vaccine for Dengue fever by 2015

BANGKOK: A vaccine for dengue fever could be a reality by 2015 - bringing relief to countries like Thailand where the disease strikes millions each year. For the estimated 220 million people infected annually, dengue fever starts with only a small mosquito bite. Two million children a year develop a potentially deadly form of the disease. More than 70 per cent of the world's population at risk for dengue fever live in ASEAN countries, and the month of June is peak dengue season. Dengue has become an epidemic due to unprecedented population growth, lack of effective mosquito control, and unchecked urbanization. Health consequences aside, families are often faced with the economic burden of treatment. In Thailand's Ratchaburi province which has some of the highest incidences of dengue in the Kingdom, Sanofi Pasteur and Mahidol University are spearheading the world's first efficacy trial for a dengue vaccine. So far, there is reason for hope. "Its really q...